1. Home
  2. PDM vs ODTX Comparison

PDM vs ODTX Comparison

Compare PDM & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piedmont Office Realty Trust Inc.

PDM

Piedmont Office Realty Trust Inc.

HOLD

Current Price

$9.80

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$27.67

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PDM
ODTX
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
PDM
ODTX
Price
$9.80
$27.67
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
858.3K
126.1K
Earning Date
04-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$564,994,000.00
N/A
Revenue This Year
$4.21
N/A
Revenue Next Year
$1.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.32
$15.10
52 Week High
$10.13
$26.49

Technical Indicators

Market Signals
Indicator
PDM
ODTX
Relative Strength Index (RSI) 55.26 76.70
Support Level $9.23 $19.84
Resistance Level $9.89 N/A
Average True Range (ATR) 0.23 1.82
MACD 0.00 0.63
Stochastic Oscillator 82.27 100.00

Price Performance

Historical Comparison
PDM
ODTX

About PDM Piedmont Office Realty Trust Inc.

Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: